|
Market Closed -
Nasdaq
05:00:00 07/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 904.35 USD | +0.16% |
|
-2.54% | +17.16% |
| 11-07 | Regeneron Pharmaceuticals Insider Sold Shares Worth $3,827,159, According to a Recent SEC Filing | MT |
| 11-05 | DZ Bank Adjusts Price Target on Regeneron Pharmaceuticals to $1,067 From $900 | MT |
| Market Cap | 90.75B 81.39B 74.39B 67.9B 128B 8,531B 132B 897B 358B 4,552B 341B 333B 14,370B | P/E 2026 * |
15.3x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 83.58B 74.96B 68.51B 62.54B 118B 7,857B 122B 826B 329B 4,192B 314B 307B 13,235B | EV / Sales 2026 * |
4.45x | EV / Sales 2027 * | 3.88x |
| Free-Float |
72.57% | Yield 2026 * |
0.42% | Yield 2027 * | 0.44% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.16% | ||
| 1 week | -2.54% | ||
| Current month | -2.54% | ||
| 1 month | +22.42% | ||
| 3 months | +17.13% | ||
| 6 months | +25.42% | ||
| Current year | +17.16% |
| 1 week | 887.04 |  | 991.73 |
| 1 month | 723.65 | | 991.73 |
| Current year | 591.52 | | 991.73 |
| 1 year | 591.52 | | 991.73 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Sell | Chief Technology Officer | -4,147 | 0.0041% | ||
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -2.54% | +39.80% | +8.64% | 90.75B | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| Average | -0.06% | -1.64% | +40.34% | +69.77% | 427.05B | |
| Weighted average by Cap. | -0.04% | -1.97% | +42.19% | +86.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.78B 16.85B 15.4B 14.05B 26.48B 1,766B 27.31B 186B 74B 942B 70.5B 68.99B 2,974B | 20.15B 18.07B 16.52B 15.08B 28.41B 1,894B 29.3B 199B 79.38B 1,011B 75.63B 74.01B 3,191B |
| Net income | 6.43B 5.76B 5.27B 4.81B 9.06B 604B 9.35B 63.49B 25.32B 322B 24.12B 23.6B 1,018B | 6.56B 5.88B 5.38B 4.91B 9.25B 617B 9.54B 64.81B 25.84B 329B 24.62B 24.09B 1,039B |
| Net Debt | -7.17B -6.43B -5.88B -5.36B -10.11B -674B -10.42B -70.82B -28.24B -360B -26.9B -26.33B -1,135B | -12.52B -11.23B -10.26B -9.37B -17.65B -1,177B -18.2B -124B -49.31B -628B -46.98B -45.98B -1,982B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | US$904.35 | +0.16% | 1,122,872 |
| 05/11/26 | US$902.90 | -2.98% | 1,407,351 |
| 04/11/26 | US$930.67 | -4.39% | 1,395,270 |
| 03/11/26 | US$973.36 | +1.26% | 1,200,307 |
| 02/11/26 | US$961.26 | +3.60% | 1,661,160 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
